Microvast Faces Class Action Lawsuit Over Alleged Disclosure Failures

The litigation, spearheaded by the firm Levi & Korsinsky, highlights a series of disclosures regarding the company’s financial health and production timelines. Plaintiffs claim that Microvast maintained optimistic gross-margin targets and Huzhou Phase 3.2 completion dates despite internal issues that were allegedly known to the firm. These included significant delays in customer rollouts and production timing problems.

The scrutiny intensified following a sharp market reaction on March 17, 2026, when Microvast shares plummeted 34.2% to close at $1.52. That drop followed a quarterly report revealing revenue of $96.5 million—well below the $136.4 million consensus—alongside a 1.0% gross margin and a $32.5 million impairment charge for specialized ESS components. Joseph E. Levi, lead counsel for the plaintiffs, argued that generic risk warnings cannot shield a company from failing to disclose specific operational hurdles that directly impact share value.

Investors are now evaluating claims under the Securities Exchange Act of 1934, specifically regarding whether repeated CFO turnover and regulatory shifts in South Korea were communicated with sufficient transparency. The court has set a deadline of September 21, 2026, for investors to apply as lead plaintiffs. Participation in the action does not require upfront out-of-pocket costs, as the case is being handled on a contingency basis.